The Johnson & Johnson Innovation unit of Johnson & Johnson (NYSE:JNJ) announced several partnerships, including collaborations concerning obesity, non-alcoholic steatohepatitis and rheumatoid arthritis.
J&J's Janssen Pharmaceuticals Inc. unit partnered with
